4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-24-006015
Director sold 10,100 shares at an average $13.51 ($136,454)
- Director acquired 10,100 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KARABELAS ARGERIS N · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $3.76 | $37,600 | 21,286 | D |
| 2024-08-01 | Exercise or conversion : show line 2 in the form 10b5-1 | +100 | $12.74 | $1,274 | 21,386 | D |
| 2024-08-01 | Sale : show line 3 in the form 10b5-1 | −9,600 | $13.45 | $129,120 | 11,786 | D |
| 2024-08-01 | Sale : show line 4 in the form 10b5-1 | −400 | $14.59 | $5,834 | 11,386 | D |
| 2024-08-01 | Sale : show line 5 in the form 10b5-1 | −100 | $15.00 | $1,500 | 11,286 | D |
| Open-market sales · 10,100 sh · avg $13.51 · $136,454 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-01 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Options (Right to Buy) | −100 | 1,400 | D |
| 2024-08-01 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Options (Right to Buy) | −10,000 | 20,000 | D |
Loading xslF345X05/primarydocument.xml…